{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"20.600","floor":"18.600"},"ipodate":{"start":"2017-05-31 00:00:00","end":"2017-06-05 00:00:00"},"minimumcapital":"10403.82","subscribed":"37.46","marketcap":"233.63億","H_marketcap":"--","pe":"147.88","codesrate":"80.21","link":"https://staticpdf.iqdii.com/stockdata/notice/Prospectus/02269/LTN20170531020_C.pdf","ipopricing":"20.600","resultdate":"2017-06-12 00:00:00","enddate":"2017-06-05 00:00:00","listeddate":"2017-06-13 00:00:00","issuenumber":"19298.25萬","issuenumberhK":"5789.50萬","issuenumberother":"13508.75萬","grayprice":"22.85","sponsors":"美林遠東有限公司,摩根士丹利亞洲有限公司,招商證券(香港)有限公司","raisemoney":"332930.00萬","use":"1、約45.1%或1,428.3百萬港元，將用于償還我們全部未清償銀行融資；\n2、約44.9%或1,420.3百萬港元，將用于建造新設施及設施改進及維護；\n3、約10%或316.5百萬港元，將用于我們的營運資金及其他一般企業用途。","shares":500,"leadagent":"美林遠東有限公司,摩根士丹利亞洲有限公司,招商證券(香港)有限公司,聯合證券有限公司","bookrunners":"美林遠東有限公司,摩根士丹利亞洲有限公司,招商證券(香港)有限公司","coordinator":"美林遠東有限公司,摩根士丹利亞洲有限公司,招商證券(香港)有限公司","firstDayOpen":"25.00","IsEiio":0,"Interestdays":7,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"摩根士丹利亞洲有限公司","code":"E02269","name":"藥明生物","fullname":"藥明生物技術有限公司"},"institutioninfo":{"principaloffice":"中國上海外高橋自貿區富特中路288號 ","registrars":"卓佳證券登記有限公司","registrarstel":"(852) 2980 1333 ","chairman":"李革","secretary":"黃躍,岑影文","telephone":"400 820 0985","substantialshareholders":"WuXi Biologics Holdings Limited(55.07%)","principalactivities":"公司是全球領先的生物制劑服務供貨商，通過公司的科學家團隊、專有技術平臺及技術知識、頂尖的實驗室以及符合cGMP的生產設施，向制藥及生物技術公司提供全面、綜合及高度定制的服務。","website":"http://www.wuxibiologics.com.cn"},"managerinfo":[{"managername":"李革","post":"主席兼非執行董事","rankno":1},{"managername":"陳智勝","post":"首席執行官兼執行董事","rankno":2},{"managername":"周偉昌","post":"首席技術官、高級副總裁兼執行董事","rankno":3}],"investorinfo":[],"TotalShareholdingPercentage":0},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":507}